药学博士课程的桥梁课程的审查
Medha D Joshi1, James A Uchizono2
1Department of Pharmaceutical Sciences, College of Pharmacy-Glendale Campus, Midwestern University, 19555 N. 59th Avenue, Glendale, AZ 85308, USA.
Currents in pharmacy teaching & learning
|June 20, 2025
概括
药学博士课程的桥梁课程增强基础知识和学术表现. 本综述总结了这些关键的准备计划的内容,交付和评估方法.
科学领域:
- 药房 教育 教育 药房 教育
- 课程开发 课程开发
背景情况:
- 药学博士 (PharmD) 课程的桥梁课程对于标准化基础知识至关重要.
- 这些课程解决知识差距,并为学生准备严格的学术要求.
- 有效的桥梁计划可以预测和改善学生的整体学业成绩.
研究的目的:
- 审查和综合现有的PharmD桥梁计划的内容,交付和评估策略.
- 为实现桥梁计划提供可用的选项提供全面的概述.
- 为了告知课程设计和提高学生准备在药房教育.
主要方法:
- 使用关键词进行了全面的文献搜索,使用关键词与药学博士课程中的桥梁计划相关.
- 系统地审查教育资源,以确定课程内容,交付和评估中的共同主题.
- 确定并讨论了评估先前数学知识的各种评估工具.
主要成果:
- 数学是药学博士桥梁课程中普遍存在的主题.
- 存在多种评估方法来评估学生的先前数学知识,包括标准化测试和特定的预测试.
- 这些课程采用了广泛的内容,交付和评估方式.
结论:
- 桥梁计划为准备药学博士学生提供了多样化的方法.
- 桥梁计划模式的选择应根据机构的具体课程量身定制.
- 桥梁计划设计与机构学术目标之间的协调对于成功至关重要.
相关概念视频
Biopharmaceutics and Pharmacokinetics: Overview
2.6K
Understanding drugs, drug products, and their performance in pharmaceutical science is pivotal. Drugs, whether simple molecules or complex compounds, are designed to interact with the body's biological systems to diagnose, treat, or prevent diseases. Drug products include various delivery systems such as tablets, capsules, injections, and inhalers. The performance of these drug products is gauged by their ability to deliver the active ingredient to the desired site of action at the...
2.6K
Drug Administration and Therapy Phases: Overview
779
Drugs, the chemical agents used in diagnosing, treating, or preventing diseases, undergo a four-phase process of development: pharmaceutic, pharmacokinetics, pharmacodynamics, and therapeutic.
The pharmaceutical phase focuses on leveraging the physicochemical properties of the drug to design and manufacture an effective product. Variants include orally administered tablets or capsules, topical creams or ointments, and parenteral-delivery solutions or emulsions.
The pharmacokinetic phase...
The pharmaceutical phase focuses on leveraging the physicochemical properties of the drug to design and manufacture an effective product. Variants include orally administered tablets or capsules, topical creams or ointments, and parenteral-delivery solutions or emulsions.
The pharmacokinetic phase...
779
Pharmacokinetics: Overview
7.2K
Pharmacokinetics is a scientific discipline that focuses on the journey of a drug within the body, encompassing four key stages: absorption, distribution, metabolism, and elimination. The first stage, absorption, involves the drug's transfer into the bloodstream. Several factors dictate the extent and speed of this process. For example, the liver often metabolizes oral drugs before they reach systemic circulation, leading to only partial absorption. In contrast, intravenous (IV)...
7.2K
Nonlinear Pharmacokinetics: Role of Transporters
101
A drug's nonlinear kinetics can be influenced by a diverse range of transporter proteins that serve as crucial players in drug distribution. These transporters, found within cells, can enhance or reduce local drug concentrations by facilitating the influx or efflux of drugs. For instance, the expression of xenobiotic transporters can be influenced by factors such as age and gender, potentially impacting the linearity of drug response.
Polymorphisms occurring in drug transporters can alter...
Polymorphisms occurring in drug transporters can alter...
101
Phase II Conjugation Reactions: Overview
359
Conjugation, a key component of phase II biotransformation reactions, is a vital process in drug detoxification. It involves transferring endogenous substances like glucuronic acid, sulfate, and glycine to drugs or their metabolites formed in phase I reactions. These conjugation reactions, often catalyzed by specific enzymes, transform potentially harmful metabolites into inactive, water-soluble forms easily excreted in urine or bile. By enhancing polarity and eliminating pharmacological...
359
Nonlinear Pharmacokinetics: Bioavailability and Protein-Drug Binding
286
When a drug follows nonlinear pharmacokinetics, its bioavailability, the amount of the drug that reaches the systemic circulation, can change with different doses. This is due to the presence of a saturable pathway. The pathway becomes saturated as the drug concentration increases, decreasing the absorption rate. Consequently, the drug's bioavailability may be lower than expected at higher doses.
To quantify the extent of bioavailability, pharmacologists often use a parameter called .
To quantify the extent of bioavailability, pharmacologists often use a parameter called .
286


